Google's $32 Billion Wiz Acquisition Faces EU Decision — Neutral
GOOG GOOGL PYMNTS — January 08, 2026A regulatory decision on Google's largest ever acquisition could be weeks away. European competition regulators will decide by Feb. 10 whether to allow the company's $32 billion acquisition of cybersecurity provider Wiz, according to a filing on the European Commission (EC) website.
Soho House's $2.7 Billion Deal to Go Private Hits a Last-Minute Funding Snag — Negative
SHCO WSJ — January 08, 2026Hotel owner MCR said it can't make a $200 million commitment in time, sending Soho House financial partners scrambling for other options.
Brazil's oil regulator puts Petrobras drilling at Foz do Amazonas on hold — Negative
PBR PBR-A Reuters — January 08, 2026Brazilian oil regulator ANP has told Petrobras that it cannot resume offshore drilling in the Foz do Amazonas basin until it provides information on a leak of synthetic fluid in the environmentally sensitive region, the agency said on Thursday.
SLB: Venezuelan Oil Can Revitalize Oilfield Services Growth (Rating Upgrade) — Positive
SLB Seeking Alpha — January 08, 2026SLB N.V. is upgraded to Buy with a $50.74/share price target, reflecting optimism around Venezuelan oil redevelopment and digital expansion. Reengagement in Venezuela could drive multi-year growth for SLB's oilfield services, though major operational impact may not materialize until late in the decade. SLB's digital initiatives, including the Tela AI assistant and AI development partnership with Shell, are positioned to generate durable, recurring revenue streams.
Bloom Energy CEO K.R. Sridhar: AI spend and infrastructure buildout will last for a long time — Neutral
BE CNBC Television — January 08, 2026K.R. Sridhar, Bloom Energy co-founder and CEO, joins 'The Exchange' to discuss how to characterize the energy deployment around AI, how quickly Bloom Energy can service the demand and much more.
World will need 50% more copper than we have today: S&P Global's Yergin — Positive
CPER JJC CNBC Television — January 08, 2026CNBC's "The Exchange" team discusses global demand for copper amid the AI boom, market outlook and more with Daniel Yergin of S&P Global.
Lilly's Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial — Positive
LLY Reuters — January 08, 2026Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis treatment Taltz, improved arthritis symptoms and drove weight loss better than Taltz alone.
EXCLUSIVE: 'Big Short' Star Danny Moses Predicts Gold Monster Rally — Prices 'Will Double From Here' — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Benzinga — January 08, 2026Gold has spent years being treated as insurance — useful, but rarely exciting. Danny Moses, best known as one of the traders featured in The Big Short, thinks that framing is already outdated.
Enliven Therapeutics Early Leukemia Drug Results Impress, Stock Soars — Positive
ELVN Benzinga — January 08, 2026Enliven Therapeutics Inc. (NASDAQ: ELVN) stock is trading higher on Thursday, with a session volume of 6.61 million compared to the average volume of 631.52 thousand as per data from Benzinga Pro.
Embassies in Venezuela plan visits for American, European oil firms, sources say — Positive
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP Reuters — January 08, 2026Foreign embassies in Venezuela are beginning to arrange visits for next week that will include representatives for American and European oil companies, two sources told Reuters, following the U.S. announcement of a $2 billion oil deal and the supply of U.S. goods to the South American country.
Defiance Daily Target 2X Short SMCI ETF (SMCZ) Trading Halt — Neutral
SMCI GlobeNewsWire — January 08, 2026MILWAUKEE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tidal Investments LLC (“Tidal”) announces that the Defiance Daily Target 2X Short SMCI ETF, (Ticker: SMCZ) was halted to allow Tidal to evaluate the accuracy of the SMCZ Net Asset Values per share (NAVs) published for January 7, 2026. Tidal determined the NAV for SMCZ required to be restated from $ 52.1477 per share to $ 54.1535 per share.
Commercial Metals Company (CMC) Q1 2026 Earnings Call Transcript — Neutral
CMC Seeking Alpha — January 08, 2026Commercial Metals Company (CMC) Q1 2026 Earnings Call Transcript
AZZ Inc. (AZZ) Q3 2026 Earnings Call Transcript
CrowdStrike to buy identity security startup SGNL for $740 million to tackle AI threats — Positive
CRWD Reuters — January 08, 2026CrowdStrike said on Thursday it would buy identity security startup SGNL in a deal valued at $740 million aiming to enhance its cybersecurity tools to help customers counter artificial intelligence-powered threats.
Equal Sector ETF Captures Market Broadening Beyond Tech — Positive
EQL ETF Trends — January 08, 2026The 2025 stock market rally was heavily concentrated in mega-cap technology names, but market strategists expect a broader rally in 2026 as earnings growth expands beyond the largest companies. Investors looking to participate in this potential rotation are turning to strategies that provide balanced exposure across all market sectors.
Why this Bank of America analyst upgraded Coinbase to buy — Positive
COIN CNBC Television — January 08, 2026CNBC's "The Exchange" team discusses the case for Coinbase with Craig Siegenthaler of Bank of America Securities.
Small-Cap Acrivon Highlights Tumor Shrinkage And Trial Progress Across Key Studies, Stock Falls — Negative
ACRV Benzinga — January 08, 2026Acrivon Therapeutics Inc. (NASDAQ: ACRV) on Thursday shared updates regarding the Phase 2 ACR-368 program and initial clinical data from the ACR-2316 Phase 1 study.
Sigma Lithium Stock Prices In Mining Volumes That Don't Exist Yet, Analyst Says — Negative
SGML Benzinga — January 08, 2026Sigma Lithium Corporation (NASDAQ: SGML) stock fell Thursday after Bank of America Securities (BofA) turned more bearish, warning that unresolved operational delays and liquidity uncertainty are overshadowing any rebound in lithium prices and limiting the company's ability to deliver meaningful near-term production.
Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored — Positive
LQDA Seeking Alpha — January 08, 2026Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and product differentiation in PAH and PH-ILD. LQDA's Yutrepia demonstrates superior tolerability, higher achievable dosing, and rapid titration versus Tyvaso, driving robust commercial uptake and market share gains. Key binary risk centers on the imminent IP litigation outcome versus United Therapeutics; multiple scenarios could impact valuation, but commercial momentum is strong.
PATH's Financial Strength: Cash, Liquidity and Flexibility Explained — Positive
PATH Zacks Investment Research — January 08, 2026PATH's $1.4B cash pile, zero debt and strong liquidity give it flexibility to invest, expand and weather volatility as shares beat industry gains.
